MedPage Today roundup flags weak eating disorder safeguards in the GLP-1 boom

More peptides

1. FDA records show mould and insects at Chinese plants making GLP-1 ingredients

   

   TNTimes Now Oct 22

   peptides typeshitSafety

   FDA records show mould and insects at Chinese plants making GLP-1 ingredients

   Both suppliers of compounded semaglutide and tirzepatide ingredients landed on the FDA import-alert list. Times Now also covers dosing mistakes with compounded vials.

   Read at Times Now
2. Penn AI study of Reddit posts flags appetite and sleep reports from gray-market retatrutide

   

   SDScience Daily Oct 22

   peptides typeshitSafety

   Penn AI study of Reddit posts flags appetite and sleep reports from gray-market retatrutide

   Penn researchers stress the self-reports in JAMA Network Open don't prove the drug caused anything, but increased appetite topped the list despite trials pointing to nausea.

   Read at Science Daily
3. Over 1,000 emergency visits tied to unapproved peptide injections in one health system

   

   FFacebook Oct 22

   peptides typeshitSafety

   Over 1,000 emergency visits tied to unapproved peptide injections in one health system

   The visits came in the country's largest healthcare system, with the trend credited to wellness influencers and young people among those affected.

   See it on Facebook
4. AAO study links GLP-1 use to earlier NAION in the second eye

   

   MXMedical Xpress Oct 22

   peptides typeshitSafety

   AAO study links GLP-1 use to earlier NAION in the second eye

   Researchers at the American Academy of Ophthalmology meeting found NAION patients on GLP-1 drugs tended to develop it in the other eye sooner.

   Read at Medical Xpress
5. FDA approves Mounjaro to lower heart attack and stroke risk in type 2 diabetes

   

   PTPharmacy Times Oct 21

   peptides typeshitNews

   FDA approves Mounjaro to lower heart attack and stroke risk in type 2 diabetes

   Tirzepatide is the first dual GIP and GLP-1 drug cleared to cut major cardiovascular events, backed by the head-to-head SURPASS-CVOT trial.

   Read at Pharmacy Times
6. AAO study finds GLP-1 link to macular degeneration flips after adjustment

   

   MXMedical Xpress Oct 21

   peptides typeshitResearch

   AAO study finds GLP-1 link to macular degeneration flips after adjustment

   Raw numbers pointed to higher AMD risk with GLP-1 drugs, but researchers say the pattern reversed once heart and metabolic factors were accounted for.

   Read at Medical Xpress